Skip to the page

Data / Form D filings / Healix Clinical Laboratory LLC

Healix Clinical Laboratory LLC: Form D filing

Healix Clinical Laboratory LLC, a biotechnology company in Bellaire, TX, filed a Form D with the SEC in 2023. The latest, on July 5, 2023, reports $2 million sold of a $2.8 million offering to 11 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4800 FOURNACE PLACE, SUITE BW3, Bellaire, TX, 77401
Phone
(281) 846-6723
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1982918

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 5, 2023New notice$2,750,000$2,000,000$750,00011May 5, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Elenora C. HuberDirector
Marc C. MintzDirector
Michael NiccoliniDirector
Kevin P. RosenblattExecutive Officer, Director
Peter K. Bryant-GreenwoodExecutive Officer, Director
Shea C. SpruillExecutive Officer, Director

Other biotechnology companies in Texas that filed recently

Every Form D from the week of Jul 3, 2023 · All recent filings in Texas · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Healix Clinical Laboratory LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.